Junjie Ma
Quanzhou, 362000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Design, synthesis, evaluation and molecular modeling of quinazoline derivatives bearing amino acids as small-molecule PD-L1 inhibitors.
Journal: Journal of computer-aided molecular design
Published: March 26, 2025
Toxicity profile of camrelizumab-based immunotherapy in older adults with advanced cancer.
Journal: Scientific reports
Published: February 08, 2024
Design, synthesis and biological evaluation of 5H-[1,2,4]triazino[5,6-b]indole derivatives bearing a pyridinocycloalkyl moiety as iron chelators.
Journal: Molecular diversity
Published: January 15, 2024
Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis.
Journal: World journal of surgical oncology
Published: October 10, 2023
Design, synthesis and biological evaluation of VEGFR-2/HDAC dual inhibitors as multitargeted antitumor agents based on fruquintinib and vorinostat.
Journal: RSC advances
Published: August 15, 2023
Advances in research on 3C-like protease (3CLpro) inhibitors against SARS-CoV-2 since 2020.
Journal: RSC medicinal chemistry
Published: September 21, 2022
Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction.
Journal: European journal of medicinal chemistry
Published: June 05, 2021
Identification and biological evaluation of novel benzothiazole derivatives bearing a pyridine-semicarbazone moiety as apoptosis inducers via activation of procaspase-3 to caspase-3.
Journal: MedChemComm
Published: December 21, 2018
Dimericursones A and B: two unprecedented hexacyclic dimeric diterpenoids from the root barks of Jatropha curcas.
Journal: Organic & biomolecular chemistry
Published: September 19, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026